# Lithium for Suicidal Behavior in Mood Disorders

> **NCT01928446** · PHASE2,PHASE3 · TERMINATED · sponsor: **VA Office of Research and Development** · enrollment: 519 (actual)

## Conditions studied

- Depressive Disorder
- Bipolar Disorder
- Suicide
- Suicide, Attempted

## Interventions

- **DRUG:** Lithium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01928446
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07-08
- **Primary completion:** 2019-08-13
- **Final completion:** 2019-08-13
- **Target enrollment:** 519 (ACTUAL)
- **Why stopped:** terminated early due to non-safety related DMC recommendations
- **Last updated:** 2024-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01928446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01928446, "Lithium for Suicidal Behavior in Mood Disorders". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01928446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*